Welcome to MS Views and News blog

MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.

Categories

Latest Blog Posts

January 30, 2012

Gilenya (an MS treatment) also prevents and reverses symptoms of ventricular hypertrophy

  • MS Drug Therapies
    /
Published January 30, 2012 A drug used to treat multiple sclerosis may also be effective at preventing and reversing the leading cause…
MS Drug Therapies

January 27, 2012

Phase 3b Trial Evaluates Tysabri as MS Treatment for Secondary Progressive MS (SPMS)

  • MS Drug Therapies
    /
  • MS Research Study and Reports
    /
  • Multiple Sclerosis
    /
  • Tysabri
    /
Biogen Idec and Elan Corporation announced a global Phase 3b study that is being conducted to evaluate the effectiveness of…
MS Drug Therapies

January 25, 2012

Nutrition for the Brain and Nervous System

  • Multiple Sclerosis
    /
  • Nutrition
    /
Multiple sclerosis (MS) is a chronic, degenerative disease of the nerves in your brain and spinal column, caused through a demyelization…
Multiple Sclerosis

January 25, 2012

MS industry insiders are candid in predicting significant changes and growth as novel therapies enter the market

  • MS Drug Therapies
    /
  • Multiple Sclerosis
    /
PRESS RELEASE – Jan. 24, 2012, 8:10 a.m. EST Industry Insiders Predict Significant Changes in Multiple SclerosisAccording to a new…
MS Drug Therapies

January 25, 2012

Merck KGaA Gets EC Approval For Rebif Use Extension For Early Multiple Sclerosis

  • MS Drug Therapies
    /
  • Multiple Sclerosis
    /
1/25/2012 2:57 AM ET (RTTNews) – Merck KGaA (MKGAY.PK: News) said the European Commission or EC has approved extension of the…
MS Drug Therapies

January 24, 2012

Synthetic Cannabis prescription drug (Sativex(R)) looks for FDA OK

  • Alternative therapies and devices for Multiple Sclerosis (MS)
    /
  • Multiple Sclerosis
    /
In this undated photo provided by GW Pharmaceuticals, a sample of the drug Sativex is shown. Sativex contains marijuana’s two…
Alternative therapies and devices for Multiple Sclerosis (MS)

January 23, 2012

NextGen Sciences Launches its 82 Protein Cerebrospinal Fluid (CSF) CNS Disease Biomarker Assay

  • MS Research Study and Reports
    /
London, UK and Ann Arbor, Michigan, US (PRWEB) January 2012 NextGen Group plc (AIM:NGG) is pleased to announce that its…
MS Research Study and Reports

January 23, 2012

FDA approves test to screen Tysabri patients

  • Multiple Sclerosis
    /
  • Tysabri
    /
The Food and Drug Administration on Friday approved a new diagnostic test to help identify patients who have an increased…
Multiple Sclerosis

January 23, 2012

AMPYRA (R) events near you

  • Alternative therapies and devices for Multiple Sclerosis (MS)
    /
AMPYRA Events provide free educational information and support on AMPYRA. These programs are open to all people living with MS,…
Alternative therapies and devices for Multiple Sclerosis (MS)

January 21, 2012

The FDA has approved the first test for assessing the risk of progressive multifocal leukoencephalopathy (PML) in patients on natalizumab (Tysabri)

  • MS Drug Therapies
    /
  • MS Research Study and Reports
    /
  • Tysabri
    /
By Kristina Fiore, Staff Writer, MedPage Today Published: January 20, 2012 SOURCE: Medical News Today The Stratify JCV Antibody ELISA test screens…
MS Drug Therapies

Categories

Latest Blog Posts